2395 — Shin Nippon Biomedical Laboratories Share News
0.000.00%
Snbl Enters Into Definitive Agreement To Acquire Satsuma Pharmaceuticals
Table: Shin Nippon Biomedical - 9-MTH group results
Table: Shin Nippon Biomedical - 6-MTH group results
Table: Shin Nippon Biomedical -Q1 group results
Table: Shin Nippon Biomedical -2021/22 group results
Table: Shin Nippon Biomedical -2021/22 group forecast
Table: Shin Nippon Biomedical -2021/22 div forecast
Table: Shin Nippon Biomedical - 9-MTH group results
Table: Shin Nippon Biomedical - 9-MTH group results
Table: Shin Nippon Biomedical -2021/22 group forecast
Table: Shin Nippon Biomedical -2021/22 div forecast
Table: Shin Nippon Biomedical - 6-MTH group results
2021 6-month group forecast
Table: Shin Nippon Biomedical -2021/22 group forecast
Table: Shin Nippon Biomedical -Q1 group results
Table: Shin Nippon Biomedical -2020/21 group results
Table: Shin Nippon Biomedical -2020/21 div forecast
Table: Shin Nippon Biomedical -2020/21 group forecast
Table: Shin Nippon Biomedical - 9-MTH group results